EX-10.6.1 2 d445191dex1061.htm REVENUE INTERESTS PURCHASE AGREEMENT, DATED AS OF OCTOBER 5, 2012 Pursuant to 17 CFR 240.24b-2, confidential information has been omitted in places marked “* * *” and has been filed separately with the Securities and...Revenue Interests Purchase Agreement • May 5th, 2020 • New York
Contract Type FiledMay 5th, 2020 JurisdictionThis REVENUE INTERESTS PURCHASE AGREEMENT (as amended, supplemented or otherwise modified from time to time, this “Agreement”) is made and entered into as of October 5, 2012, by and between AxoGen, Inc., a Minnesota corporation (the “Company”), and PDL BioPharma, Inc., a Delaware corporation (“Purchaser”).
July 26, 2013Revenue Interests Purchase Agreement • July 30th, 2013 • AxoGen, Inc. • Electromedical & electrotherapeutic apparatus • New York
Contract Type FiledJuly 30th, 2013 Company Industry JurisdictionReference hereby is made to that certain Revenue Interests Purchase Agreement (the “Revenue Purchase Agreement”), dated as of October 5, 2012 by and between AxoGen, Inc., a Minnesota corporation (the “Company”), and PDL BioPharma, Inc., a Delaware corporation (“PDL”). Capitalized terms used herein but not otherwise defined herein shall have the meanings set forth in the Revenue Purchase Agreement.